Pre-surgery boot camp aims to cut complications in pancreatic cancer patients
NCT ID NCT04469504
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study tests a 4-week prehabilitation program combining exercise, nutritional supplements, and psychological support for patients with sarcopenia (muscle loss) who are about to have pancreatic cancer surgery. The goal is to see if this program reduces serious complications like pancreatic fistulas. About 158 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prehabilitation program (exercise, nutritional supplementation, psychological support) and perioperative immunonutrition (Oral Impact)
- What this could lead to
- If it works, this program could reduce serious complications after pancreatic cancer surgery for patients with muscle loss.
- What could go wrong
- This is a relatively small, early-stage trial. The program is demanding and may be hard for some patients to complete. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hop Claude Huriez Chu Lille
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- Could muscle loss predict stroke recovery?
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can nerve changes explain Age-Related muscle loss?
- MRI might reveal hidden pancreatic risks in obesity